# Presenting Quantitative Efficacy and Risk Information in  Direct-to-Consumer (DTC) Promotional Labeling and Advertisements - FDA Guidance Document

Source: https://www.keypedia.com/guidances/guidance-document/presenting-quantitative-efficacy-and-risk-information-in-direct-to-consumer-dtc-promotional-labeling-and-advertisements/bb6d5d7c-0aa7-47cd-9c04-8a080c2201b7

> FDA guidance document: Presenting Quantitative Efficacy and Risk Information in  Direct-to-Consumer (DTC) Promotional Labeling and Advertisements. Issue date: December 12, 2023. Get complete insights and analysis.

---

## Details

- Title: Presenting Quantitative Efficacy and Risk Information in  Direct-to-Consumer (DTC) Promotional Labeling and Advertisements
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2023-12-12
- Last Changed: 2023-12-11
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2018-D-2613">FDA-2018-D-2613</a>

## Related Documents

- [Product Name Placement, Size, and Prominence in Advertising and Promotional Labeling-Final](https://www.keypedia.com/guidances/guidance-document/product-name-placement-size-and-prominence-in-advertising-and-promotional-labeling-final/fa68136f-ad70-49ea-a8cd-cc47e646f4a1)
- [Formal Dispute Resolution: Sponsor Appeals Above the Division Level Guidance for Industry and Review Staff](https://www.keypedia.com/guidances/guidance-document/formal-dispute-resolution-sponsor-appeals-above-the-division-level-guidance-for-industry-and-review-staff/1802a54c-173d-4641-9744-9b0ce8679736)
- [Special Protocol Assessment Guidance for Industry](https://www.keypedia.com/guidances/guidance-document/special-protocol-assessment-guidance-for-industry/2565ab98-6128-47ba-b033-f84934855d60)